FTY720 alters the composition of T-lymphocyte subpopulations in the peripheral blood compartment of renal transplant patients.
Boehler
T
T
Department of Nephrology, Charité, Campus Charité-Mitte, Humboldt-University, Berlin, Germany. torsten.boehler@charite.de
Schuetz
M
M
Budde
K
K
Neumayer
H
H
Waiser
J
J
D015703:Antigens, CD / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D000068876:Fingolimod Hydrochloride; D005434:Flow Cytometry; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D018655:Lymphocyte Count; D011409:Propylene Glycols / Q000009:adverse effects*; D013110:Sphingosine / Q000031:analogs & derivatives; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology*; D013601:T-Lymphocytes / Q000187:drug effects
D015703:Antigens, CD; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine